<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01965132</url>
  </required_header>
  <id_info>
    <org_study_id>KOBIO_1</org_study_id>
    <nct_id>NCT01965132</nct_id>
  </id_info>
  <brief_title>Korean College of Rheumatology Biologics Registry</brief_title>
  <acronym>KOBIO</acronym>
  <official_title>Korean College of Rheumatology Biologics Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      We plan to establish a nationwide Biologics Registry (in the form of an inception cohort) to
      study the safety profiles in rheumatoid arthritis, ankylosing spondylitis and psoriatic
      arthritis patients receiving biologic agents.As this registry is to observe the &quot;real world&quot;
      use of anti-rheumatic treatments under routine clinical practice, no hypothesis to prove is
      planned.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This registry is a multi-centre, prospective, observational program that will gather and
      analyze data on patients being treated with biologics in Korea. In contrast to a controlled
      clinical trial, there is no imposed experimental intervention and solely the patients'
      physicians will determine the patient's treatment. Thus, the data captured and reported in
      this registry will reflect a &quot;real world&quot; approach to the treatment with biologics. There
      will be no additional visit or laboratory test done outside the routine clinical practice.
      Selection of biologic agent, dosing and treatment duration are at the discretion of the
      investigator. Informed consent will be obtained from the patient prior to the collection of
      any data.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2013</start_date>
  <completion_date type="Anticipated">June 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Number of participants with adverse events during the use of biologics in Korean patients with Rheumatic diseases</measure>
    <time_frame>up to 5 years</time_frame>
    <description>Patient will be followed on a yearly basis. Adverse events based on MedDRAÂ® during the observational period will be filled out on each follow up. Adverse events will also be assessed in the case of switching or discontinuation of biologics.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">3500</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <condition>Ankylosing Spondylitis</condition>
  <condition>Psoriatic Arthritis</condition>
  <arm_group>
    <arm_group_label>Biologic DMARD</arm_group_label>
    <description>Korean patients with rheumatoid arthritis, ankylosing spondylitis or psoriatic arthritis who will initiate, restart or switch to a biologic agent (etanercept, adalimumab, infliximab, golimumab, tocilizumab, abatacept, rituximab, ustekinumab, secukinumab)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Biologic DMARD</intervention_name>
    <arm_group_label>Biologic DMARD</arm_group_label>
    <other_name>etanercept, adalimumab, infliximab, golimumab, tocilizumab, abatacept, rituximab, ustekinumab, secukinumab</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients of the following disease who will initiate, restart or switch to a biologic agent

          1. Rheumatoid arthritis (RA)

          2. Ankylosing spondylitis (AS)

          3. Psoriatic arthritis (PsA)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients diagnosed with RA, AS or PsA

          -  RA deemed by their rheumatologist to require treatment with a biologic or non-biologic
             DMARDs

          -  AS or PsA patients who are to initiate, restart or switch to a biologic agent

          -  Patients who provide a written consent of participating in this registry (data
             collection and review).

        Exclusion Criteria:

          -  RA, AS, PsA patients who are already on biologics upon screening
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yeonguk Song, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Taehwan Kim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hanyang University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Seunggi Kwak, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>THE CATHOLIC UNIV.OF KOREA SEOUL ST.MARY'S HOSPITAL</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sinseok Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chonnam National University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jaejun Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Samsung Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Changhun Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>WONKWANG UNIV. HOSPITAL</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Changgeun Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asan Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ran Song, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>KYUNG HEE NATIONAL MEDICAL CENTER</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Donghyeok Shin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Eulji General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Changhee Seo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ajou University School of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sangil Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gyeongsang National University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jungyoon Choi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Daegu Catholic University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Youngok Jung, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hallym University Kangnam Sacred Heart Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sungjae Choi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Korea University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gowoon Joo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Inha University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jimin Oh, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>SAM Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Heejung Ryu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gachon University Gil Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jinseok Kim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jeju National University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mihye Kwon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>KONYANG UNIV. HOSPITAL</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Juhyun Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Inje University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Soojin Yoo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chungnam National University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Guiyoung Kang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>THE CATHOLIC UNIV. OF KOREA INCHEON ST. MARY'S HOSPITAL</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Youngho Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Korea University Guro Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sangwoo Im, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dong-A University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sungkyu Kim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Daegu Catholic University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yongbum Park, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Severance Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Chanhong Jeon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Soonchunhyang University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Daehyun Yu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hanyang University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Chanbum Choi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hanyang University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sanghun Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Konkuk University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Youngmo Kang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kyungpook National University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jungsoo Song, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chung-Ang University Hosptial, Chung-Ang University College of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jisoo Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>EWHA E-HOSPITAL</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sungwook Kang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chungnam National University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sungsoo Kim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gangneung Asan Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yongwook Park, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chonnam National University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kyunghee Jung, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Inha University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yujung Ha, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Myongji Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jaebum Jeon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>HANYANG UNIVERSITY HOSITAL</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eunbong Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kichul Shin, MD</last_name>
    <email>kideb1@snu.ac.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>SMG-SNU Boramae Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>07061</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kichul Shin, MD</last_name>
      <phone>+8228703204</phone>
      <email>kideb1@snu.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Kichul Shin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 11, 2013</study_first_submitted>
  <study_first_submitted_qc>October 15, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 18, 2013</study_first_posted>
  <last_update_submitted>March 2, 2017</last_update_submitted>
  <last_update_submitted_qc>March 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Kichul Shin</investigator_full_name>
    <investigator_title>Director of KOBIO registry</investigator_title>
  </responsible_party>
  <keyword>Rheumatiod Arhthritis</keyword>
  <keyword>Ankylosing spondylitis</keyword>
  <keyword>Psoriatic arthritis</keyword>
  <keyword>Biologic agents</keyword>
  <keyword>Cohort studies</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
    <mesh_term>Spondylitis</mesh_term>
    <mesh_term>Spondylitis, Ankylosing</mesh_term>
    <mesh_term>Arthritis, Psoriatic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rituximab</mesh_term>
    <mesh_term>Etanercept</mesh_term>
    <mesh_term>Abatacept</mesh_term>
    <mesh_term>Adalimumab</mesh_term>
    <mesh_term>Infliximab</mesh_term>
    <mesh_term>Ustekinumab</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

